258 related articles for article (PubMed ID: 10968936)
1. Possible role of endogenous retinoid (Vitamin A) toxicity in the pathophysiology of primary biliary cirrhosis.
Erickson JM; Mawson AR
J Theor Biol; 2000 Sep; 206(1):47-54. PubMed ID: 10968936
[TBL] [Abstract][Full Text] [Related]
2. Immunostaining of plasma cells in primary biliary cirrhosis.
Daniels JA; Torbenson M; Anders RA; Boitnott JK
Am J Clin Pathol; 2009 Feb; 131(2):243-9. PubMed ID: 19141384
[TBL] [Abstract][Full Text] [Related]
3. Decreased serum leptin levels in primary biliary cirrhosis: a link between metabolism and autoimmunity?
Rieger R; Oertelt S; Selmi C; Invernizzi P; Podda M; Gershwin ME
Ann N Y Acad Sci; 2005 Jun; 1051():211-7. PubMed ID: 16126961
[TBL] [Abstract][Full Text] [Related]
4. Primary biliary cirrhosis: solving the enigma.
Giorgini A; Selmi C; Invernizzi P; Podda M; Zuin M; Gershwin ME
Ann N Y Acad Sci; 2005 Jun; 1051():185-93. PubMed ID: 16126958
[TBL] [Abstract][Full Text] [Related]
5. The immunopathology of primary biliary cirrhosis: thoughts for the millennium.
Sasaki M; Ansari AA; Nakanuma Y; Coppel RL; Keeffe EB; Gershwin ME
Arch Immunol Ther Exp (Warsz); 2000; 48(1):1-10. PubMed ID: 10722225
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and pathological analysis on characteristics of primary biliary cirrhosis].
Zhou GD; Zhao JM; Wang SS; Sun YL; Meng EH; Zhang TH; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):483-6. PubMed ID: 12939182
[TBL] [Abstract][Full Text] [Related]
7. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis.
Haruta I; Hashimoto E; Kato Y; Kikuchi K; Kato H; Yagi J; Uchiyama T; Kobayash M; Shiratori K
Autoimmunity; 2006 Mar; 39(2):129-35. PubMed ID: 16698669
[TBL] [Abstract][Full Text] [Related]
8. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis.
Medina JF; MartÃnez-Ansó ; Vazquez JJ; Prieto J
Hepatology; 1997 Jan; 25(1):12-7. PubMed ID: 8985258
[TBL] [Abstract][Full Text] [Related]
9. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
10. Primary biliary cirrhosis: from induction to destruction.
Nishio A; Bass NM; Luketic VA; Coppel RL; Gershwin ME
Semin Gastrointest Dis; 2001 Apr; 12(2):89-102. PubMed ID: 11352123
[TBL] [Abstract][Full Text] [Related]
11. [Primary biliary cirrhosis].
Poupon R
Rev Prat; 1991 May; 41(13):1161-5. PubMed ID: 2063116
[TBL] [Abstract][Full Text] [Related]
12. Presentation and diagnosis of primary biliary cirrhosis in the 21st century.
Kumagi T; Onji M
Clin Liver Dis; 2008 May; 12(2):243-59; vii. PubMed ID: 18456178
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of primary biliary cirrhosis.
Nishio A; Keeffe EB; Ishibashi H; Gershwin EM
Med Sci Monit; 2000; 6(1):181-93. PubMed ID: 11208308
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
Tsuneyama K; Harada K; Yasoshima M; Hiramatsu K; Mackay CR; Mackay IR; Gershwin ME; Nakanuma Y
J Pathol; 2001 Jan; 193(1):102-9. PubMed ID: 11169522
[TBL] [Abstract][Full Text] [Related]
15. Correlation between disappearance of the intrahepatic bile ducts and histologic changes in the liver in primary biliary cirrhosis.
Nakanuma Y; Miyamura H; Ohta G; Kobayashi K; Kato Y; Hattori N
Am J Gastroenterol; 1981 Dec; 76(6):506-10. PubMed ID: 7331981
[TBL] [Abstract][Full Text] [Related]
16. Primary biliary cirrhosis: does X mark the spot?
Selmi C; Invernizzi P; Miozzo M; Podda M; Gershwin ME
Autoimmun Rev; 2004 Nov; 3(7-8):493-9. PubMed ID: 15546796
[TBL] [Abstract][Full Text] [Related]
17. Genes and (auto)immunity in primary biliary cirrhosis.
Selmi C; Invernizzi P; Zuin M; Podda M; Seldin MF; Gershwin ME
Genes Immun; 2005 Oct; 6(7):543-56. PubMed ID: 16034472
[TBL] [Abstract][Full Text] [Related]
18. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
19. Treatment of primary biliary cirrhosis.
Kowdley KV; Kaplan MM
Gastroenterologist; 1993 Sep; 1(3):199-210. PubMed ID: 8049896
[TBL] [Abstract][Full Text] [Related]
20. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis.
Wang AP; Migita K; Ito M; Takii Y; Daikoku M; Yokoyama T; Komori A; Nakamura M; Yatsuhashi H; Ishibashi H
J Autoimmun; 2005 Aug; 25(1):85-91. PubMed ID: 16006099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
